MASCC Headlines

MASCC Headlines

Connect with MASCC in FacebookTwitterYouTube and LinkedIn


2015 MASCC/ISOO Meeting A Great Success

The 2015 Annual Meeting of MASCC/ISOO took place in Copenhagen, Denmark, June 25-27. Meeting Chair Jørn Herrstedt and the Scientific Committee put together an exciting program of presentations, workshops, discussions, and debates.  >> Highlights of the 2015 MASCC/ISOO Annual Meeting, Copenhagen

 
Jørn Herrstedt Awarded MASCC’s Distinguished Service Award

Jørn Herrstedt, MD, DMSci, was the recipient of MASCC’s Distinguished Service Award for 2015. The Award recognizes meritorious achievement and outstanding contributions to the Society and its mission. Candidates are nominated by their peers in recognition of exemplary leadership and accomplishments in supporting the Society’s mission.

 
Lidia Schapira Named Editor-in-Chief of Cancer.Net

Lidia Schapira, MD, FASCO, has been named the new Editor-in-Chief of Cancer.Net, the award-winning patient information website of the American Society of Clinical Oncology (ASCO). Cancer.Net helps patients, families, and caregivers make informed healthcare decisions by providing timely, comprehensive, and peer-reviewed information.

 
Netupitant Palonosetron

FDA and EU Commission Approval for Netupitant/Palonosetron (Akynzeo) - In May, 2015, the EU Commission also approved Akynzeo for the prevention of chemotherapy-induced nausea and vomiting. The decision, based on the opinion issued by the Committee for Medicinal Products for Human Use (CHMP), applies to all 28 European Union member countries, as well as Iceland, Liechtenstein, and Norway.

 
Palliative Care in Oncology Symposium

Media  Dorothy Keefe, Keynote Speaker at Palliative Care in Oncology Symposium: Symptom Science and Supportive Care

Dorothy Keefe, MD, MBBS, FRACP, FRCP, spoke at the opening session and also delivered a Keynote Address, at the Palliative Care in Oncology Symposium. The symposium, cosponsored by the American Society of Clinical Oncology (ASCO), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Society for Radiation Oncology (ASTRO), and MASCC, was held in Boston, Massachusetts, October 24-25, 2014. Dr. Keefe is Director South Australian Cancer Centre, Professor of Cancer Medicine at University of Adelaide, and immediate Past President of MASCC. She served on both the Planning Committee and the Steering Committee for this year’s Palliative Care Symposium.

 
Guidelines: Bone Health in Cancer Patients

In September, 2014, The European Society for Medical Oncology (ESMO) published clinical practice guidelines for maintaining bone health in patients with cancer. The guidelines address both multidisciplinary treatments for reducing skeletal effects of metastatic disease and strategies for minimizing treatment-induced skeletal damage. The guidelines article was published in the Annals of Oncology by R. Coleman, J. J. Body, M. Aapro, P.  Hadji, and J. Herrstedt on behalf of the ESMO Guidelines Working Group.*

 
Paz Fernández-Ortega Receives EONS Lifetime Achievement Award

The European Oncology Nursing Society has awarded its 2014 Lifetime Achievement Award to Paz Fernández-Ortega, RN, MSc, PhD. 

 
2014 MASCC DSA Dorothy Keefe

Dorothy M. K. Keefe, MD, FRACP, FRCP, MBBS, was the recipient of MASCC’s 2014 Distinguished Service Award (DSA). The DSA, MASCC’s most prestigious award, recognizes meritorious service and outstanding contributions to the society and its mission.

 
Update on the Prevention and Control of Noncommunicable Diseases

This historic UN Summit on Noncommunicable Diseases (NCDs) brought together over 30 Heads of State, Ministers of Health, and other policy makers and resulted in the adoption of a Political Declaration on NCDs. This was only the second such declaration of its kind to address a health issue on a global scale. In December, 2013, the Director-General of the World Health Organization (WHO) reported to the UN Secretary-General on progress since September, 2011 toward the prevention, control, and monitoring of NCDs. 

 
Outpatient Management of Pulmonary Embolism in Cancer

Among people with pulmonary embolisms (PE), cancer is associated with adverse outcomes. Also, PEs are fairly common among patients with cancer and are often incidental findings on CT, rather than sudden, symptomatic events. While patients with low-risk PE are often treated on an outpatient basis, there is little evidence for the feasibility of managing cancer patients with low-risk PE in this way. Some of these patients might be good candidates for outpatient treatment.

 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 9 of 10